EDBI

EDBI, established in 1991, is a Singapore-based corporate venture capital arm of the Singapore Economic Development Board. The organization focuses on investing in high-growth sectors, particularly in information and communication technology, emerging technology, healthcare, and advanced manufacturing. As a government-backed entity, EDBI aims to support companies in achieving their growth ambitions by providing not only capital but also access to a broad network and resources. With a commitment to patient capital, EDBI assists businesses looking to expand in Asia and beyond, fostering innovation and development in strategic industries.

Valerie Chua

Principal

Andrew Krishna Ekaputra

Principal

Christine Giam

Partner

Charmaine Kng

Partner

Rongyang Lim

Senior Principal

Voon Kheong Liow

Managing Director

Paul Ng

CEO

Jolene Ooi

Senior Principal

Allen Poon

Principal

Sin Cheng Siah

Senior Principal

Chung Hang Tang

Principal

Kenneth Teo

Senior Principal

Terence Teo

Senior Principal

Choo Heng Tong

Executive Vice President, Investments

Chia Li Yeung

Managing Partner, Investments

Andrew Ekaputra Ph.D

Principal

Past deals in Singapore

Tessa Therapeutics

Series A in 2022
Tessa Therapeutics Pte Ltd. is a biotechnology company focused on developing innovative cancer immunotherapies, specifically targeting solid tumors. Founded in 2011 and based in Singapore, the company specializes in creating virus-specific T cells and CAR T cells aimed at treating lymphoma. By advancing these therapies, Tessa Therapeutics seeks to provide healthcare providers with effective options to improve the lives of cancer patients.

Neuron Mobility

Series B in 2022
Neuron Mobility Pte. Ltd. provides electric scooters and bicycles rental services around Singapore. The company was incorporated in 2016 and is based in Singapore.

RVAC Medicines

Series B in 2022
Developer of mRNA platform designed to build a diverse pipeline of innovative medicines. The company provides end-to-end GMP manufacturing capabilities, MSAT infrastructure for process scale-up and tech transfer, and develops single and multi-mRNA/DNA products, enabling healthcare professionals to tackle infectious diseases.

Us2.ai

Series A in 2022
Us2.ai is a Singapore-based company that develops artificial intelligence-driven software and digital tools specifically for echocardiography. The company offers online solutions that streamline access to results from echocardiogram analyses and heart ultrasounds. Its machine learning platform automates the traditionally manual process of measuring and interpreting echocardiograms, enhancing the efficiency of cardiovascular research and clinical trials. By providing AI-based decision support tools, Us2.ai aims to save physicians time, improve the accuracy of clinical trials for pharmaceutical companies, and assist in the detection of conditions that are often overlooked or difficult to diagnose in hospital settings.

Beam

Series B in 2022
Beam Mobility Holdings Pte. Ltd. is a micro-mobility company that offers electric scooters for rent through a user-friendly mobile application. Established in 2018 and based in Singapore, Beam aims to enhance urban mobility by providing a network of shared e-scooters that can be easily accessed on a pay-per-use basis. The company promotes responsible parking by incentivizing users to return scooters to designated parking spots, thereby minimizing clutter on city streets. By leveraging Internet of Things technology, Beam contributes to improved last-mile connectivity, helps alleviate traffic congestion, and supports environmental sustainability efforts.

MiRXES

Series C in 2022
MiRXES Pte. Ltd. develops life science research tools and molecular diagnostic tests or research and clinical diagnostic use. It offers RT-qPCR assays, assay panels, spike-in RNA kits, and biomarker discovery solutions. The company was founded in 2014 and is based in Singapore.

Modalku

Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia, designed to connect small businesses seeking loans with lenders looking to fund these loans. By leveraging technology, Modalku offers borrowers access to financing options that may not be available through traditional channels, often at lower interest rates. Lenders participating in the platform can achieve returns that surpass those typically found in bank deposits and traditional investment products. This marketplace lending model has been successfully implemented in various countries, including the USA, UK, China, and Singapore, demonstrating its effectiveness in supporting small business growth.

Funding Societies

Series C in 2022
Funding Societies Pte. Ltd. is a peer-to-peer financing platform based in Singapore, founded in 2015. It connects investors with small and medium-sized enterprises (SMEs) seeking funding, thereby addressing financial inclusion challenges and making credit-worthy SMEs more bankable. The platform offers a range of flexible financing options, including micro and term loans, as well as invoice financing, supported by advanced credit scoring and risk assessment models. Since its inception, Funding Societies has facilitated over 3.3 million business loans, amounting to more than S$1.8 billion in funding. The company has received multiple accolades, including the Global Excellence Award from ITU Telecom, and holds operating licenses from regulators in Singapore, Indonesia, and Malaysia, making it a pioneer in the region's peer-to-peer lending landscape.

Next Gen Foods

Series A in 2022
Next Gen Foods is a food-tech startup that offers plant-based meats products. We use plants to create a delicious and satisfying meat experience that will make you forget animal meat even exists.

Sleek

Series A in 2021
Sleek Tech Pte. Ltd. is a Singapore-based company that simplifies the incorporation and management of businesses through an online platform. Established in 2017, Sleek offers a range of services including company incorporation, registration, company secretary, accounting, work visas, and compliance management. The company targets startups, entrepreneurs, small and medium enterprises, and investors, providing them with 100% digital solutions to streamline governance and regulatory processes. By leveraging technology, Sleek addresses the inefficiencies of traditional, paper-based procedures, making it easier for clients to manage their corporate obligations in Singapore and Hong Kong. Since its inception, Sleek has successfully incorporated hundreds of companies, enhancing the experience for entrepreneurs and investors alike.

bolttech

Series A in 2021
Bolttech is a technology company that specializes in building a digital ecosystem for insurance and protection products. It offers a platform that utilizes artificial intelligence to enhance the point-of-sale experience for users. The company's services encompass a wide range of insurance options, including device protection, travel, motor, property, and life insurance. By integrating digital and data-driven capabilities, Bolttech facilitates seamless connections between insurers, distributors, and customers, streamlining the process of buying and selling insurance products. This focus on efficiency and accessibility allows clients to easily engage with various insurance and protection offerings.

Endowus

Venture Round in 2021
Operator of a financial advisory and personalized investment company intended to grow the clients' money. The company offers access to funds managed by global investment management businesses with long track records of delivering returns that are not normally available to retail investors, enabling investors to access institutional share-class funds at institutional-level fees, charging a single access fee that includes advice, investment, rebalancing, transfers, and brokerage.

ShopBack

Series E in 2021
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

bolttech

Series A in 2021
Bolttech is a technology company that specializes in building a digital ecosystem for insurance and protection products. It offers a platform that utilizes artificial intelligence to enhance the point-of-sale experience for users. The company's services encompass a wide range of insurance options, including device protection, travel, motor, property, and life insurance. By integrating digital and data-driven capabilities, Bolttech facilitates seamless connections between insurers, distributors, and customers, streamlining the process of buying and selling insurance products. This focus on efficiency and accessibility allows clients to easily engage with various insurance and protection offerings.

Neuroglee Health

Series A in 2021
Neuroglee Health is a company that discovers, develops, and commercializes a digital therapeutic platform aimed at patients with neurodegenerative diseases, particularly in the early stages. Founded in 2020 and based in Singapore, the company offers digital therapeutics and monitoring tools, including NG-001, which is designed for the symptomatic treatment of Alzheimer's disease and mild cognitive impairment. This software captures digital biomarkers and utilizes machine-learning algorithms to personalize therapy by adjusting mobile-based activities based on cognitive function, mood, and behavior. Neuroglee Health's approach not only assists in preserving cognition and independence for patients but also provides insights into drug efficacy, enhancing the overall treatment experience and supporting the development of pharmacotherapy for neurodegenerative conditions.

MiRXES

Series C in 2021
MiRXES Pte. Ltd. develops life science research tools and molecular diagnostic tests or research and clinical diagnostic use. It offers RT-qPCR assays, assay panels, spike-in RNA kits, and biomarker discovery solutions. The company was founded in 2014 and is based in Singapore.

SCI Ecommerce

Venture Round in 2021
Provider of marketing services intended to help in planning and executing digital marketing campaigns. The company offers services that increase brand awareness and conversion rate, which drive sales on various platforms, enabling clients to navigate and manage the complex supply chain and earn more profits.

Nuevocor

Series A in 2021
Nuevocor is a preclinical-stage biopharmaceutical company dedicated to the development of gene therapy-based treatments aimed at restoring cardiac function in patients with cardiovascular diseases. The company's research focuses on genetic cardiomyopathies that involve abnormal mechanobiology. By modulating mechanical force transduction, Nuevocor's innovative approaches seek to address the underlying mechanisms of these diseases, ultimately enabling healthcare providers to improve cardiac function in affected individuals.

Esco Lifesciences

Series A in 2021
Esco Lifesciences Group specializes in providing technology-based products and services aimed at the life sciences and healthcare sectors. The company supports various aspects of academic research, scientific discoveries, clinical practice, and biopharmaceutical research and development. Its offerings are designed to facilitate the invention, discovery, and commercialization processes in the industry, ultimately enabling customers to lead healthier and safer lives through advanced technological solutions.

Engine Biosciences

Series A in 2021
Engine Biosciences Pte. Ltd. is a biotechnology company that specializes in drug discovery by leveraging machine learning and genomics. Founded in 2014 and based in Singapore, the company has developed a validated platform that integrates high-throughput wet lab experimentation with artificial intelligence algorithms. This unique approach enables the mapping and analysis of complex biological networks and gene interactions, facilitating the identification of disease-driving errors. The platform supports researchers and drug developers in various aspects of drug discovery, including target discovery, drug repositioning, and pathway analysis. Engine Biosciences collaborates with American Fortune 500 companies and research institutions, aiming to accelerate and reduce the costs associated with the research and development process for new medical therapies. The company’s leadership team includes experts from renowned institutions such as MIT, Harvard, Mayo Clinic, and UCSD.

Hummingbird Bioscience

Series C in 2021
Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

Neon

Private Equity Round in 2021
Cityneon Holdings Limited, founded in 1956 and based in Singapore, specializes in providing interior architecture and experiential environment services globally. The company caters to multinational corporations, governments, and private organizations by offering a wide range of services, including event management, logistics, and project consulting. Cityneon is involved in the design and installation of exhibitions, pavilions, and thematic environments, as well as the decoration of commercial spaces and museums. It also rents reusable modules and furnishings and engages in the production of environmental graphic materials for events. Additionally, the company has diversified into exhibition production based on popular franchises, such as Jurassic Park, and is involved in civil engineering and real estate activities. Over the years, Cityneon has evolved from its beginnings as a supplier of electrical appliances to a leader in creating immersive brand experiences.

ImmunoScape

Venture Round in 2021
ImmunoScape PTE. LTD. is a Singapore-based company founded in 2016 that specializes in immunotherapy, focusing on the deep profiling of immune cells and the identification of tumor antigen-specific T cells. Utilizing advanced mass cytometry techniques, the company analyzes alterations in immune cells to facilitate biomarker and target identification. ImmunoScape provides pharmaceutical and biotechnology firms with analytical tools and software designed to enhance the development of immunotherapies by offering insights from clinical trial patient data. In addition to its core services, the company is also involved in vaccine development, supporting the research and clinical phases of immunotherapy efficacy and safety.

Vesta

Venture Round in 2020
Vesta Corporation specializes in electronic payment solutions, catering primarily to e-commerce and telecommunications industries globally. The company offers various merchant services, including vSafe for Small to Midsize Businesses, an effective payment and fraud protection solution for smaller digital goods merchants, and vSafe for Enterprise, which provides comprehensive payment management and fraud prevention for larger organizations. Additionally, Vesta's vGuaranteed service supports online retailers by minimizing fraud risk. The company also offers consumer lending solutions, such as DelayPay, which allows prepaid wireless customers to make installment payments for phone refills. Vesta emphasizes revenue growth for its partners by leveraging a real-time decisioning platform that utilizes data science and machine learning to evaluate the risk of online transactions. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally with centers in the United States, Ireland, China, and an office in Singapore.

Transcelestial

Series A in 2020
Transcelestial Technologies Pte. Ltd., established in 2016 and based in Singapore, specializes in developing a long-distance, point-to-point wireless communication network using laser technology. This innovative infrastructure aims to provide a high-speed space data network applicable to both terrestrial and satellite communication. By leveraging lasers, Transcelestial's network is designed to transmit data at speeds up to 1000 times faster than existing technologies, offering robust connectivity that is resistant to jamming and does not require spectrum pre-allocation or regulatory compliance. Their solutions are intended to enhance global communication capabilities across various sectors, including ground and deep-space applications.

Doctor Anywhere

Series B in 2020
Doctor Anywhere Pte Ltd is a Singapore-based telehealth company that provides an online platform for health and wellness solutions. Established in 2016, the company specializes in video consultations, allowing patients to consult with licensed and registered doctors for various medical needs. Its digital platform offers on-demand healthcare services that are designed to be simple, seamless, and convenient, catering to the evolving lifestyle preferences of users. By integrating a range of health services, Doctor Anywhere enables patients to receive appropriate diagnoses, medication, and e-prescriptions, facilitating access to healthcare anytime and anywhere. The company aims to improve health outcomes through technology, addressing modern healthcare challenges and enhancing the overall patient experience.

ShopBack

Series B in 2020
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

eko.ai

Funding Round in 2020
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in artificial intelligence software aimed at the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound imaging to enhance cardiovascular risk assessment. Eko.ai employs machine learning to automate processes, providing research teams with fully classified, machine learning-ready databases and a variety of tools, including segmentation and validation models. By collaborating with clinician scientists, sonographers, and deep learning experts, Eko.ai serves laboratories worldwide, aiming to improve productivity and patient outcomes within hospital systems.

SWAT Mobility

Series A in 2019
SWAT Mobility’s vehicle-routing technology helps companies, transport operators and government agencies around the world solve complex transportation challenges. We are the first in Asia to run high-capacity vehicle pooling services that is both on-demand and dynamically-routed. We also have proven results in helping our clients reduce transportation costs, improve city connectivity and reduce traffic congestion woes. Our technology tops the industry Li & Lim's benchmark, and with our cutting-edge smart mobility optimisation engine, we are future-ready for the world of autonomous vehicles.

M-DAQ

Venture Round in 2019
M-DAQ Pte Ltd (formerly known as Summit Investment Pte Ltd) was founded by a group of veterans from the FX and Securities Industries with experience averaging 15 years amongst the key members. M-DAQ is an innovative and unique solution, providing a platform to price and trade any exchange-traded products in more than one currency by blending ‘executable’ FX rates into equities and futures products. M-DAQ is the IP owner and holds the key relationships with the National Exchanges and the Global FX Banks. M-DAQ handles the entire consultancy work for each Exchange to be enabled on M-DAQ Solution, and provides the Exchange and the FX Consortium Banks with a license to use the M-DAQ solution. In addition, the partner Exchange will receive a revenue share of the net FX margins. The Exchange partners continues to operate the new cross-currency platform under existing in-country regulatory framework.

Neon

Private Equity Round in 2019
Cityneon Holdings Limited, founded in 1956 and based in Singapore, specializes in providing interior architecture and experiential environment services globally. The company caters to multinational corporations, governments, and private organizations by offering a wide range of services, including event management, logistics, and project consulting. Cityneon is involved in the design and installation of exhibitions, pavilions, and thematic environments, as well as the decoration of commercial spaces and museums. It also rents reusable modules and furnishings and engages in the production of environmental graphic materials for events. Additionally, the company has diversified into exhibition production based on popular franchises, such as Jurassic Park, and is involved in civil engineering and real estate activities. Over the years, Cityneon has evolved from its beginnings as a supplier of electrical appliances to a leader in creating immersive brand experiences.

Structo

Series D in 2019
Structo Pte. Ltd., established in 2014 and based in Singapore, specializes in developing and manufacturing industrial-grade 3D printers and materials. The company utilizes proprietary liquid crystal dynamic mask stereolithography (MSLA) technology to produce high-speed 3D printing solutions, particularly for digital dentistry applications. Structo's innovations enable users to achieve higher throughput at reduced costs, all while maintaining exceptional print quality. Through its advanced technology, the company aims to transform dental business models by enhancing efficiency and effectiveness in the 3D printing process.

DataRobot

Series E in 2019
DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.

Circles.Life

Venture Round in 2019
Circles.Life is a young, innovative telco, homegrown in Singapore with a mission to re-imagine how mobile services are built and delivered with you in mind. They do this by offering the best no-contract mobile plan, unlimited bonus data and an unparalleled customer experience.

ShopBack

Series B in 2019
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

Carro

Series B in 2019
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

Zilingo

Series D in 2019
Zilingo Pte Ltd. operates a digital marketplace for fashion, beauty, and lifestyle products, facilitating transactions between sellers and buyers. Founded in 2015 by Ankiti Bose and Dhruv Kapoor, the company is based in Singapore, with additional offices in New York and Los Angeles. Zilingo's platform allows buyers to shop conveniently from various sources, including malls and street markets, while also enabling them to engage with sellers through chat, make payments, and stay updated on global trends. For sellers, Zilingo offers tools to create personalized online stores, access free end-to-end logistics services, and utilize analytics to enhance sales. The company's mission is to democratize the fashion industry by leveraging technology to connect creators and producers, making the market more accessible and transparent for all participants.

Carousell

Series C in 2018
Carousell is a classifieds marketplace that allows people to buy and sell preloved items. It is a Singapore-based consumer-to-consumer marketplace app for iOS and Android. The Carousell marketplace has a diverse range of products across a variety of categories, including cars, lifestyle, gadgets, and fashion accessories. It has been ranked as the top Shopping app in Singapore, Taiwan, Hong Kong, and Australia, and is backed by leading international Venture Capitalists Sequoia Capital, Rakuten Ventures, 500 Startups, Golden Gate Ventures, and QuestVC. Launched in Aug 2012, Carousell began in Singapore and has expanded to 19 cities around the world, spanning 7 countries.

Rotimatic

Series C in 2018
Zimplistic, founded in 2008 by Rishi Israni and Pranoti Nagarkar, is a kitchen robotics startup focused on improving healthy eating through innovative technology. Its flagship product, Rotimatic, is the world's first fully automatic roti-making appliance that utilizes artificial intelligence and machine learning to prepare fresh, homemade rotis with minimal human intervention. Users can create hot and delicious rotis in under a minute by simply pressing a button, making it a convenient solution for busy households. Since its launch in 2016, Rotimatic has garnered significant global interest, serving millions of rotis across various countries, including Singapore, the US, UK, Canada, Australia, and New Zealand. The appliance stands out for its compact design and user-friendly operation, aiming to simplify meal preparation while promoting healthier eating habits. With its innovative approach, Rotimatic has disrupted the kitchen appliance market and continues to attract health-conscious consumers seeking convenient cooking solutions.

Rotimatic

Series C in 2018
Zimplistic, founded in 2008 by Rishi Israni and Pranoti Nagarkar, is a kitchen robotics startup focused on improving healthy eating through innovative technology. Its flagship product, Rotimatic, is the world's first fully automatic roti-making appliance that utilizes artificial intelligence and machine learning to prepare fresh, homemade rotis with minimal human intervention. Users can create hot and delicious rotis in under a minute by simply pressing a button, making it a convenient solution for busy households. Since its launch in 2016, Rotimatic has garnered significant global interest, serving millions of rotis across various countries, including Singapore, the US, UK, Canada, Australia, and New Zealand. The appliance stands out for its compact design and user-friendly operation, aiming to simplify meal preparation while promoting healthier eating habits. With its innovative approach, Rotimatic has disrupted the kitchen appliance market and continues to attract health-conscious consumers seeking convenient cooking solutions.

H3 Dynamics

Series B in 2018
H3 Dynamics Holdings Pte. Ltd. specializes in developing artificial intelligence-based solutions and robotic systems, particularly in the fields of security, surveillance, and inspection. Founded in 2015 and based in Singapore, the company has created a range of products, including tele-robotics systems that provide security, communication, and drone charging services. H3 Dynamics also offers an online micro-services platform, H3 Zoom.AI, which processes image data to identify surface defects. By deploying robotic scanners at client sites, the company autonomously collects data, which is then analyzed and transformed into detailed inspection reports. This service is applicable across various sectors, including military, aerospace, telecommunications, energy, and transportation. The company's technology enables real-time response to incidents and supports seamless rectification of work orders, enhancing operational efficiency for its clients.

Engine Biosciences

Seed Round in 2018
Engine Biosciences Pte. Ltd. is a biotechnology company that specializes in drug discovery by leveraging machine learning and genomics. Founded in 2014 and based in Singapore, the company has developed a validated platform that integrates high-throughput wet lab experimentation with artificial intelligence algorithms. This unique approach enables the mapping and analysis of complex biological networks and gene interactions, facilitating the identification of disease-driving errors. The platform supports researchers and drug developers in various aspects of drug discovery, including target discovery, drug repositioning, and pathway analysis. Engine Biosciences collaborates with American Fortune 500 companies and research institutions, aiming to accelerate and reduce the costs associated with the research and development process for new medical therapies. The company’s leadership team includes experts from renowned institutions such as MIT, Harvard, Mayo Clinic, and UCSD.

Tessa Therapeutics

Venture Round in 2017
Tessa Therapeutics Pte Ltd. is a biotechnology company focused on developing innovative cancer immunotherapies, specifically targeting solid tumors. Founded in 2011 and based in Singapore, the company specializes in creating virus-specific T cells and CAR T cells aimed at treating lymphoma. By advancing these therapies, Tessa Therapeutics seeks to provide healthcare providers with effective options to improve the lives of cancer patients.

Appier

Series C in 2017
Appier Inc. is a technology company that specializes in artificial intelligence solutions to enhance customer engagement for enterprises. Founded in 2012 and headquartered in Taipei, Taiwan, Appier offers a range of AI-driven products, including Aideal, which aids in accelerating purchase decisions; AIQUA, a platform for proactive customer engagement based on user behavior; AIXON, a data science platform that enriches customer data for better audience insights and predictive modeling; and CrossX, an AI-powered advertising solution designed for optimal campaign performance. The company serves approximately 1,000 global brands and agencies, facilitating real-time bidding, programmatic media buying, and deep learning capabilities to help businesses target and retain customers effectively. Appier operates in 14 markets across Asia, including major cities such as Singapore, Kuala Lumpur, Tokyo, and Sydney.

CXA Group

Series B in 2017
From a modest start in 2013, when they had just three Fortune 500 clients, CXA has grown to become Asia’s leading Insurtech start-up - affirmed by over 600 clients and backed by a group of astute investors who understand the value and transformative potential of CXA’s groundbreaking platform. Employees are now able to proactively manage their health by choosing the best-suited insurance, wellness and disease management offerings while employers are able to view aggregated health and claims analytics of their workforce to prioritise interventions that reduce costs and improve workplace health, productivity and employee engagement.

Knewton

Series F in 2016
Knewton, Inc. is a developer of an online adaptive learning engine that personalizes education for students by providing tailored recommendations on what to study. The platform also equips teachers with analytics to enhance their support for individual students and offers publishers insights to create more effective digital educational products. Knewton's technology serves a range of subjects, including math, economics, and sciences, and is utilized by educational institutions and companies worldwide. In addition to its flagship product, Knewton offers Alta, an integrated adaptive learning courseware for higher education. Founded in 2008 and headquartered in New York, Knewton has expanded its presence internationally with offices in London, Tokyo, Singapore, and Dubai. The company has been recognized for its innovation in education technology, earning accolades such as being named a “Technology Pioneer” by the World Economic Forum.

Smaato

Series E in 2014
Smaato Inc. operates a real-time advertising platform that serves mobile publishers, application developers, and advertisers globally. Founded in 2005 and headquartered in San Francisco, California, with additional offices in Hamburg, Germany; New York; Shanghai; Beijing; and Singapore, Smaato provides an enterprise-grade advertising server known as the SPX platform. This platform facilitates mobile monetization by connecting various demand and supply sources, enabling clients to enhance their effective cost per mille (eCPMs) and optimize their monetization strategies. Smaato's technology allows publishers to deliver tailored and engaging experiences to their audiences while leveraging advanced targeting capabilities and competitive intelligence to maximize revenue potential.

Amaranth Medical

Series B in 2013
Amaranth Medical, Inc., a medical device company, develops and manufactures bioresorbable scaffolds for vascular and nonvascular applications. It offers FORTITUDE, a bioresorbable coronary scaffold that assists the artery during the remodeling process following an interventional procedure. The company was incorporated in 2005 and is based in Mountain View, California. It has research and manufacturing operations in Singapore; and Silicon Valley, California.

Smaato

Series D in 2011
Smaato Inc. operates a real-time advertising platform that serves mobile publishers, application developers, and advertisers globally. Founded in 2005 and headquartered in San Francisco, California, with additional offices in Hamburg, Germany; New York; Shanghai; Beijing; and Singapore, Smaato provides an enterprise-grade advertising server known as the SPX platform. This platform facilitates mobile monetization by connecting various demand and supply sources, enabling clients to enhance their effective cost per mille (eCPMs) and optimize their monetization strategies. Smaato's technology allows publishers to deliver tailored and engaging experiences to their audiences while leveraging advanced targeting capabilities and competitive intelligence to maximize revenue potential.

Crisp Mobile

Series C in 2011
Crisp Mobile is a leader in mobile advertising technology, dedicated to assisting brands in engaging customers at the point of purchase through mobile devices. The company offers an innovative mobile customer activation platform known as Crisp MoCA, which provides a comprehensive solution for brands to enhance their retail presence. With a strong focus on delivering data-driven experiences, Crisp enables retailers and consumer packaged goods companies to effectively target and activate mobile shoppers at the right time and place. The platform boasts sophisticated capabilities to measure campaign success, ensuring that brands can track their impact on store visits and sales. Headquartered in New York and with an office in Singapore, Crisp Mobile has established itself as a preferred partner for leading brands in the industry.

Smaato

Series C in 2011
Smaato Inc. operates a real-time advertising platform that serves mobile publishers, application developers, and advertisers globally. Founded in 2005 and headquartered in San Francisco, California, with additional offices in Hamburg, Germany; New York; Shanghai; Beijing; and Singapore, Smaato provides an enterprise-grade advertising server known as the SPX platform. This platform facilitates mobile monetization by connecting various demand and supply sources, enabling clients to enhance their effective cost per mille (eCPMs) and optimize their monetization strategies. Smaato's technology allows publishers to deliver tailored and engaging experiences to their audiences while leveraging advanced targeting capabilities and competitive intelligence to maximize revenue potential.

MerLion Pharma

Series C in 2010
MerLion Pharmaceuticals GmbH a pharmaceutical company, develops antibacterial drugs and biological products. The company offers finafloxacin, a fluoroquinolone antibiotic for the treatment of infection. The company was founded in 2008 and is based in Berlin, Germany. As of August 21, 2006, MerLion Pharmaceuticals GmbH operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

S*Bio

Venture Round in 2008
S*BIO Pte, Ltd., a biotech company, focuses on the discovery and clinical development of novel targeted small drugs for the treatment of cancer. It serves the biotechnology industry in Singapore. The company was founded in 2000 and is based in Singapore, Singapore. S*BIO Pte, Ltd. operates as a subsidiary of Chiron Corporation Limited.

Amaranth Medical

Series A in 2006
Amaranth Medical, Inc., a medical device company, develops and manufactures bioresorbable scaffolds for vascular and nonvascular applications. It offers FORTITUDE, a bioresorbable coronary scaffold that assists the artery during the remodeling process following an interventional procedure. The company was incorporated in 2005 and is based in Mountain View, California. It has research and manufacturing operations in Singapore; and Silicon Valley, California.

Amaranth Medical

Seed Round in 2005
Amaranth Medical, Inc., a medical device company, develops and manufactures bioresorbable scaffolds for vascular and nonvascular applications. It offers FORTITUDE, a bioresorbable coronary scaffold that assists the artery during the remodeling process following an interventional procedure. The company was incorporated in 2005 and is based in Mountain View, California. It has research and manufacturing operations in Singapore; and Silicon Valley, California.

MerLion Pharma

Series A in 2002
MerLion Pharmaceuticals GmbH a pharmaceutical company, develops antibacterial drugs and biological products. The company offers finafloxacin, a fluoroquinolone antibiotic for the treatment of infection. The company was founded in 2008 and is based in Berlin, Germany. As of August 21, 2006, MerLion Pharmaceuticals GmbH operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.